Literature DB >> 78321

Schizophrenia as dopamine-deficiency disease.

G Chouinard, B D Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 78321     DOI： 10.1016/s0140-6736(78)91409-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Correction of apathic-abulic manifestations of the processual defect by cholinotropic preparations.

Authors:  A V Golenkov; V O Lukin
Journal:  Neurosci Behav Physiol       Date:  1992 May-Jun

Review 2.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 3.  Is schizophrenia a dopamine supersensitivity psychotic reaction?

Authors:  Mary V Seeman; Philip Seeman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-12       Impact factor: 5.067

4.  Dopamine agonists for negative symptoms in schizophrenia.

Authors:  D J King
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

5.  Elevated dopa decarboxylase activity in living brain of patients with psychosis.

Authors:  J Reith; C Benkelfat; A Sherwin; Y Yasuhara; H Kuwabara; F Andermann; S Bachneff; P Cumming; M Diksic; S E Dyve; P Etienne; A C Evans; S Lal; M Shevell; G Savard; D F Wong; G Chouinard; A Gjedde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

6.  Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.

Authors:  J D Wilson; D J King; B Sheridan
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

Review 7.  A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system.

Authors:  D E Comings
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

8.  Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.

Authors:  Kengo Oishi; Nobuhisa Kanahara; Masayuki Takase; Yasunori Oda; Yusuke Nakata; Tomihisa Niitsu; Masatomo Ishikawa; Yasunori Sato; Masaomi Iyo
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.